I-Cordis, LLC
SAINT LOUIS, United States · Founded 2019
- Headquarters
- SAINT LOUIS, Missouri
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2B
- Website
- i-cordis.com
About
I-Cordis LLC is a clinical-stage cardiovascular company developing innovative immunomodulatory molecules to treat heart failure with preserved ejection fraction (HFpEF) and related cardiovascular diseases. The company is optimizing pirfenidone, a marketed drug, leveraging advances in cardiac immunology. I-Cordis was recognized as a 2023 Deep Tech Pioneer and received a Phase II SBIR grant of $1.55M from NHLBI.
Summary
I-Cordis, LLC is a Biotech company based in SAINT LOUIS, United States, founded in 2019.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/i-cordis-llc"><img src="https://indexed.vc/api/badge/company/i-cordis-llc" alt="I-Cordis, LLC on Indexed.vc" width="260" height="76" /></a>